Advertisement

Latest Articles in Regulatory

Delhi HC Dismisses Plea Seeking Ban On Anti-Tobacco Ad Campaign At Cinemas

The Petitioner, being a non-smoker and not a consumer of any tobacco products, is wrongfully subjected to the compulsory watching of these graphic images in the anti-tobacco health spots during a film in the cinema hall and during TV programmes at home

Read More

Akums Gets Fixed Drug Combination Approval From DCGI For Erectile Dysfunction

Tamsulosin is primarily used when an enlarged prostate impedes normal urine flow and bladder emptying. Conversely, Tadalafil's mechanism of action supports the development of a naturally induced erection, contingent upon sexual stimulation

Read More

Strides Pharma Gets Tentative Approval For Treatment For HIV

Dolutegravir, Lamivudine and Tenofovir Disproxil Fumurate tablets are a complete regimen for the treatment of HIV‐1 infection in adults and pediatric patients weighing at least 35kgs

Read More

Zydus Gets Final Approval For A Hormonal Transdermal Patch From USFDA

Ahmedabad-based Zydus Lifesciences has received final approval from the United States Food and Drug Administration for Norelgestromin and Ethinyl Estradiol Transdermal system, 150mcg /35mcg per day

Read More

DCGI Issues Alert On Abbott's Digene Gel For Quality; Abbott Voluntarily Recalls Product In India

The Drug Controller General Of India (DCGI) Dr Rajeev Raghuvanshi has red-flagged a Digene Gel product manufactured by the pharmaceutical company Abbott India. In a letter dated 31 August 2023, the DCGI issued an alert calling the impugned product 'unsafe' and the use of which may result in adverse

Read More

WHO Warns Of A Spurious Rare Disease Drug Defitelio Floating In India

Defitelio (defibrotide) is indicated for the treatment of severe hepatic veno-occlusive disease (VOD) also known as sinusoidal obstructive syndrome (SOS) in haematopoietic stem-cell transplantation (HSCT) therapy

Read More

Zydus Gets Final Nod For An Antibacterial Drug From USFDA

Ahmedabad-based Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) for Erythromycin Tablets USP, 250 mg and 500 mg a generic equivalent of US reference listed drug, Erythromycin Tablets

Read More

Zydus Receives Approval From USFDA For Isotretinoin Capsules

Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) for Isotretinoin Capsules. The drug will be manufactured at the group’s formulation manufacturing facility in Moraiya, Ahmedabad (India)

Read More

Glenmark Pulls Back 1,200 Bottles Of Hypertension Drug From US

As per the US Food and Drug Administration (USFDA), Glenmark Pharmaceuticals is in the process of recalling 1,200 bottles of a generic drug which is used in the treatment of high blood pressure, in the US market due to a manufacturing fault

Read More

Gland Pharma Gets 2 Observations On Form 483 In A Pre-market Inspection By USFDA

Gland Pharma informed that the USFDA inspected the Pashamylaram Facility at Hyderabad from 23 August 2023 to 26 August 2023

Read More